학술논문
Frontline PET-Directed Therapy with Brentuximab Vedotin Plus AVD Followed By Nivolumab Consolidation in Patients with Limited Stage Hodgkin Lymphoma
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:1751-1752
Subject
Language
ISSN
0006-4971